Ceres licenses DNA Browser Software to Bayer CropScience

Ceres, Inc. (NASDAQ: CERE), an agricultural biotechnology and seed company, today announced that the company has licensed its Persephone genome visualization application to Bayer CropScience. The multi-year software license and collaboration agreement provides a non-exclusive license to Bayer as well as professional services including support, customizations and maintenance. Bayer is the second multi-national life sciences company to license Persephone as its primary genome browser.

Originally developed for in-house use by Ceres, Persephone allows researchers to rapidly zoom in and out of massive amounts of genetic data, from a chromosome level to a single building block of DNA. On top of this data, users can layer and cross reference related information in much the same way geographic mapping services allow users to add weather information or business locations to a geographic map.

“We are proud to have Bayer select Persephone as its primary genome browser for its in-house R&D, and we look forward to working with Bayer for many years to come,” said Richard Hamilton, President and CEO of Ceres. “The explosion of low cost full genome DNA sequencing, from plant science to biomedical research, is creating incredibly large data sets that are rich sources of information if mined effectively. Persephone provides us with a significant near-term opportunity to leverage our expertise in bioinformatics and genetic analysis, while accelerating our own internal research and development work,” Hamilton said.

Dr. Jakob de Vlieg, Head of the Computational Life Sciences group at Bayer CropScience said, “Our company will benefit from implementing this integrated solution, as this platform is allowing interactive querying and integrated visualization of various omics data. The Persephone genome browser impressed both our geneticists and bioinformaticians with its performance and user friendly interface. Persephone will allow them to make decisions on experimental approaches.”

Click here to read the complete release at ceres.net

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.